Arizona Democratic Party: McSally Sides With Pharma On Keeping Prices High
Targeted News Service (Press Releases)
PHOENIX, Arizona, Feb. 20 -- The Arizona Democratic Party issued the following news release:
* * *
- McSally has received tens of thousands of dollars in campaign support from pharmaceutical corporations, while failing to hold them accountable for jacking up prices on Arizonans
* * *
At tonight's Trump rally, Martha McSally highlighted "big pharma cheating and boxing out competition and jacking up the price on our seniors." But the truth is that McSally is part of the problem in Washington when it comes to spiking prescription drug costs: McSally has received tens of thousands of dollars in campaign support from pharmaceutical corporations, while failing to hold them accountable for jacking up prices on Arizonans.
McSally -- who has taken at least $106,200 in corporate PAC contributions from pharmaceutical corporations -- has sided with Mitch McConnell, as he blocks a U.S. House-passed bipartisan plan to let Medicare negotiate for lower prescription drug prices.
The Medicare drug price negotiation bill is estimated to help bring down pricing for certain treatments by thousands of dollars per month.
But a pharma-linked group that's already spent $1 million to keep McSally's vote in the Senate opposes the bill, so rather than come out to support Medicare drug price negotiation, McSally is siding with her "cheating" big pharma backers who are "jacking up the price on our seniors."
Virginia Community Gathers To Aid In Flood Cleanup, Repairs
Advisor News
- Amid slew of corporate tax ideas, Newsom chose one likely to hit people’s premiums
- The biggest risk to your clients’ financial plans isn’t market volatility
- Initiative looks at how caregiving impacts workplace benefits
- Will rising retirement needs spark an annuity boom?
- Living longer, retiring poorer: Why fragmented systems are failing Americans
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- Fortitude Re Completes $500 Million FABN Issuance
- Reframing retirement income for greater certainty
- Jackson Introduces Dow Jones Industrial Average Index Option, Flexible Premiums, Six-Year Rate Guarantee in Latest Registered Index-Linked Annuity Launch
- Senior Market Sales® Fortifies Annuity Reach With Acquisition of Retirement Planning Firm Stratton & Company
More Annuity NewsHealth/Employee Benefits News
- Health Care Notes: Clover star rating raised after court-ordered recalculation
- NORTH CAROLINA WOMAN CHARGED WITH CONSPIRACY TO COMMIT IMMIGRATION FRAUD, VA DISABILITY FRAUD
- Cigna tops Conn. Fortune 500
- ACA premium shock: Health insurers request hikes up to 30% for 2027
- More Hoosiers go uninsured, resulting in higher emergency department usage
More Health/Employee Benefits NewsLife Insurance News
- Globe Life Inc. (NYSE: GL) Records 52-Week High Thursday Morning
- Greg Lindberg moves to halt $1.65B restitution order, claims he ‘overpaid’
- Fidelity Investments® to Expand Target Date Lineup With Launch of Guaranteed Income Solution
- KBRA Releases Research – Private Credit: Much Ado About Nothing – Perspectives on Columbia Business School Paper About Private Ratings
- VUL sales skyrocket in Q1, signaling major market shift
More Life Insurance News